OrbiMed Genesis GP LLC's Net Worth

$620 Million

Estimate Recalculated Feb 23, 2024 05:15PM EST

Who is OrbiMed Genesis GP LLC?

OrbiMed Genesis GP LLC has an estimated net worth of $620 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., Keros Therapeutics, Inc., PMV Pharmaceuticals, Inc., Theseus Pharmaceuticals, Inc., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., Kinnate Biopharma Inc., Ikena Oncology, Inc., Sierra Oncology, Inc., Galecto, Inc., Decibel Therapeutics, Inc., Compass Therapeutics, Inc., Terns Pharmaceuticals, Inc., Enliven Therapeutics, Inc., Disc Medicine, Inc., scPharmaceuticals Inc., Pandion Therapeutics Holdco LLC, ALPINE IMMUNE SCIENCES, INC., and LogicBio Therapeutics, Inc..

SEC CIK

OrbiMed Genesis GP LLC's CIK is 0001808744

Past Insider Trading and Trends

2022 was OrbiMed Genesis GP LLC's most active year for acquiring shares with 36 total transactions. OrbiMed Genesis GP LLC's most active month to acquire stocks was the month of April. 2023 was OrbiMed Genesis GP LLC's most active year for disposing of shares, totalling 49 transactions. OrbiMed Genesis GP LLC's most active month to dispose stocks was the month of March. 2021 saw OrbiMed Genesis GP LLC paying a total of $102,548,267.30 for 59,817,218 shares, this is the most they've acquired in one year. In 2022 OrbiMed Genesis GP LLC cashed out on 4,682,322 shares for a total of $119,872,996.08, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc. (ACET) Snapshot price: $3.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.01%
3.13M
$2.40
$7,500,000.00
9.77M
Jan 25
Form 4
+12.10%
875K
$2.09
$1,828,750.00
8.11M
Jun 27
Form 4
+765.30%
214.28K
$14.00
$2,999,990.00
242.28K
Dec 10
No matching records found

Keros Therapeutics, Inc. (KROS) Snapshot price: $51.755

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+170.39%
1.27M
$16.00
$6,003,200.00
2.01M
Apr 13
Form 3
0
0
No matching records found

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.715

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-87.79K
$2.23
-$195,762.78
0
Nov 22
Form 4
-23.02%
-26.25K
$15.93
-$418,210.29
87.79K
May 26
Form 4
-100.00%
-474.50K
$21.63
-$10,264,415.00
0
Mar 29 - Mar 31
Form 4
7.06M
$18.00
$8,550,000.00
7.06M
Sep 25 - Sep 29
Form 3
0
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.095

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-17.71M
0
Feb 14
Form 4
+2.78%
479.93K
$3.05
$1,463,792.60
17.71M
Jul 17
Form 4
+1.16%
192K
$5.21
$1,000,320.00
16.73M
Nov 7
Form 4
+0.97%
158.42K
$9.97
$1,578,717.49
16.54M
Jan 19 - Jan 21
Form 4
+0.27%
44.72K
$9.90
$442,750.42
16.38M
Jan 11 - Jan 13
Form 4
16.84M
$16.00
16.84M
Oct 12
Form 3
0
0
No matching records found

Janux Therapeutics, Inc. (JANX) Snapshot price: $8.82

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.60%
-40.40K
$20.30
-$820,120.00
2.49M
Dec 29
Form 4
-4.51%
-119.40K
$19.00
-$2,268,600.00
2.53M
Dec 21
Form 4
-12.93%
-393.30K
$19.07
-$7,500,231.00
2.65M
Dec 16
Form 4
3.04M
$17.00
3.04M
Jun 15
Form 3
0
0
No matching records found